SCHEMBL9696811

SCHEMBL9696811

CCOC(=O)CC1CN2CCC1C2

nearest known ligand 0.43

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ CHRM1 P11229 2/20 0.40
▸ CHRNB2 P17787 1/20 0.38
▸ CHRNA4 P43681 1/20 0.38
▸ POLB P06746 1/20 0.37
▸ CHRM2 P08172 3/20 0.37
▸ KMT2A Q03164 2/20 0.37
▸ MEN1 O00255 1/20 0.37
▸ CYP2D6 P10635 1/20 0.37
▸ GAA P10253 2/20 0.35
▸ MGAM O43451 1/20 0.35
▸ SI P14410 1/20 0.35
▸ MGAM2 Q2M2H8 1/20 0.35
▸ FDFT1 P37268 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25606145 1.00 CHRM1 (0.40) CHRM1CHRNB2CHRNA4POLBCHRM2
SCHEMBL7319174 0.92 CHRM2 (0.41) CHRM1CHRNB2CHRNA4POLBCHRM2
SCHEMBL23315373 0.92 CHRM2 (0.41) CHRM1CHRNB2CHRNA4POLBCHRM2
SCHEMBL23435952 0.92 CHRM2 (0.41) CHRM1CHRNB2CHRNA4POLBCHRM2
SCHEMBL9697942 0.83 CHRM1 (0.45) CHRM1CHRNB2CHRNA4CHRM2KMT2A
SCHEMBL7328671 0.76 ALDH1A1 (0.40) CHRM1CHRNB2CHRNA4POLBCHRM2
SCHEMBL21095889 0.75 SLC6A12 (0.39) CHRM1CHRNB2CHRNA4CHRM2KMT2A
SCHEMBL21095754 0.75 SLC6A12 (0.39) CHRM1CHRNB2CHRNA4CHRM2KMT2A
SCHEMBL9698254 0.75 CHRM1 (0.38) CHRM1CHRNB2CHRNA4CHRM2KMT2A
SCHEMBL12614403 0.75 CHRM2 (0.43) CHRM1CHRM2KMT2AMEN1CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3724188-B1 PROGRANULIN MODULATORS AND METHODS OF USING THE SAME ARKUDA THERAPEUTICS (US) 2023-06-07 — — EP disclosed
WO-2019118528-A1 PROGRANULIN MODULATORS AND METHODS OF USING THE SAME ARKUDA THERAPEUTICS (US) 2019-06-20 — — WO disclosed
US-5091397-A Cognition activators BEECHAM GROUP P.L.C. (GB) 1992-02-25 — — US disclosed
EP-0363085-A2 Novel compounds BEECHAM GROUP PLC (GB) 1990-04-11 — — EP disclosed
Send feedback